Poland· PL-100374275
Tiopental Panpharma
A thiopental product containing thiopentalum natricum et natrii carbonas, registered in Poland by Panpharma. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Thiopental is registered in 10 of 19 countries.
Countries holding a registration under ATC N01AF03 (thiopental), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Thiopental · ATC N01AF03
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Thiopentalum natricum et natrii carbonas
- Manufacturer
- Panpharma
- Country
- Poland (PL)
- ATC code
- N01AF03
- ATC class
- Thiopental
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909991389291
- gtin05909991389277
- gtin05909991389260
- gtin03391133870873
- gtin05909991389284
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
56 interactions on record for thiopental.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Thiopental · interactions on record
56 records
- 5 severe
- 44 moderate
- 7 minor
Most severe, free to view
- WarfarinB01AA03severe
- EthanolB05XX04severe
- EthanolV03AB16severe
- EthanolV03AZ01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N01AF03
Thiopental, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/14a82b83-6bba-4328-9244-9e881822e89d GET /v1/drugs/14a82b83-6bba-4328-9244-9e881822e89d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "1 g",
"packaging": "05909991389260 ¦ Lz ¦ 130539\n1 fiol. 1 g proszku\n03391133870873 ¦ Lz ¦ 130540\n10 fiol. 1 g proszku\n05909991389284 ¦ Lz ¦ 130541\n25 fiol. 1 g proszku\n05909991389291 ¦ Lz ¦ 130542\n50 fiol. 1 g proszku\n05909991389277 ¦ Lz ¦ Skasowane ¦ 136292\n10 fiol. proszku",
"substance": "Thiopentalum natricum et natrii carbonas 1 g",
"common_name": "Thiopentalum natricum et natrii carbonas",
"pl_product_id": "100374275",
"pozwolenie_nr": "25069",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about thiopental.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.